EMEA-001006-PIP02-15

Key facts

Invented name
Ofev
Active substance
nintedanib
Therapeutic area
Pneumology-allergology
Decision number
P/0233/2015
PIP number
EMEA-001006-PIP02-15
Pharmaceutical form(s)
  • Capsule
  • soft
Condition(s) / indication(s)
Treatment of systemic sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132778271
E-mail: paediatrics@boehringer-ingelheim.com

 

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating